-
Study aim
-
The effect of continuous heparin infusion on the duration of peripheral central venous catheter (PICC) patency in preterm neonates
-
Design
-
This clinical trial has a control group, with a case group (administration of 0.5 U / ml / hr intravenous fluids), randomized, double blind. The sample size will be 100 in each group.
-
Settings and conduct
-
All preterm infants (gestational age less than 34 weeks) admitted to the NICU ward of Alzahra Hospital in Tabriz, who according to the neonatal specialist, require a PICC catheter. Then premature infants with a properly implanted catheter will be randomly divided into two groups of heparin and normal saline recipients, who will not be responsible for dividing the randomes in the follow-up study. In this study, physicians, nurses, and researchers will be blind to the study groups.
-
Participants/Inclusion and exclusion criteria
-
All preterm infants (gestational age less than 34 weeks) admitted to the NICU ward of Alzahra Hospital in Tabriz, who according to the neonatal specialist, require a PICC catheter.
All preterm infants (less than 34 weeks gestational age) admitted to the NICU ward of Alzahra Hospital in Tabriz will be included in the study, according to the neonatal specialist, who require a PICC catheter. Neonates with bleeding potential, grade 3 and 4 intravascular hemorrhage, newly diagnosed sepsis, thrombocytopenia, DIC, arrhythmia, and congenital malformations will be excluded. Also increased PTT (more than 71 seconds) and neonates needing to receive heparin will be excluded.
-
Intervention groups
-
Two groups of heparin and normal saline
-
Main outcome variables
-
The primary outcome is the duration of catheter use, ie the time between insertion and exit of the catheter due to obstruction.